RT PCR

Walgreens Launches COVID-19 Index to Advance Rapid Detection of Omicron and Track Variant Activity by State

Retrieved on: 
Wednesday, January 19, 2022
Research, Medical Supplies, Infectious Diseases, Specialty, Convenience Store, Home Goods, Pharmaceutical, Health, Retail, Science, PCR, Patient, Technology, Walgreens Boots Alliance, RT, Data, NGS, COVID-19, Pharmacy, Severe acute respiratory syndrome coronavirus 2, Partnership, Health, Time, Nasdaq, Government, Privacy, Pharmacist, Method, Multimedia, WBA, Risk, RT PCR, Data analysis, Aegis, Omicron, Pharmaceutical industry, Walgreens, the Walgreens COVID-19 Index, Walgreens, Aegis Sciences Corporation, THE WALGREENS COVID-19 INDEX, WALGREENS, AEGIS SCIENCES CORPORATION

New data from the Walgreens COVID-19 Index shows more than 95% of all positive COVID-19 cases are presumed to be the Omicron variant.

Key Points: 
  • New data from the Walgreens COVID-19 Index shows more than 95% of all positive COVID-19 cases are presumed to be the Omicron variant.
  • View the full release here: https://www.businesswire.com/news/home/20220119005357/en/
    Data captured in the Walgreens COVID-19 Index can track the spread of the Omicron variant within 24 to 48 hours, more quickly than other methods.
  • The Walgreens COVID-19 Index is based on proprietary data from PCR testing services administered by Walgreens and performed by its testing partner Aegis Sciences.
  • All data presented in the Walgreens COVID-19 Index is aggregated and de-identified to protect individuals privacy.

Global PCR and Realtime PCR Testing Market Forecast to Decline at a CAGR of -10.93% from 2020 to reach $12,546.83 Million in 2025 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 22, 2021
Health, Biotechnology, Natural sciences, Molecular biology, Laboratory techniques, Chemistry, Physical sciences, Polymerase chain reaction, Amplifiers, Biotechnology, Real-time polymerase chain reaction, RT PCR, ddPCR

The global polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market reached a value of nearly $22,380 million in 2020, having increasing at a compound annual growth rate (CAGR) of 28.11% since 2015.

Key Points: 
  • The global polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market reached a value of nearly $22,380 million in 2020, having increasing at a compound annual growth rate (CAGR) of 28.11% since 2015.
  • The global polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market is expected to stabilize and reach $17,054.69 million in 2030, at a CAGR of 6.33%.
  • North America was the largest region in the global polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market, accounting for 34.5% of the total in 2020.
  • The polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market size will decline the least in Indonesia at $85.8 million.

Tetracore, Inc. Introduces First USDA-Licensed Real-Time PCR Test for the Detection of Foot and Mouth Disease Virus in Bovine, Swine and Ovine

Retrieved on: 
Friday, June 11, 2021
Natural sciences, Molecular biology, Laboratory techniques, Branches of biology, Articles, Polymerase chain reaction, Biotechnology, Reverse transcription polymerase chain reaction, Real-time polymerase chain reaction, RT PCR, In silico PCR

The VetAlert FMDV RNAhigh-performance test kit was developed by Tetracore scientists and will be commercialized and sold by Tetracore.

Key Points: 
  • The VetAlert FMDV RNAhigh-performance test kit was developed by Tetracore scientists and will be commercialized and sold by Tetracore.
  • Nearly two decades ago, Tetracore validated and published a real-time RT-PCR assay for FMDV, as described by Callahan et al.
  • The primer and probe set from the publication became part of the OIE and USDA reference test methods.
  • Tetracore is a Registered Trademark and VetAlert is a Trademark of Tetracore, Inc.
    View original content to download multimedia: http://www.prnewswire.com/news-releases/tetracore-inc-introduces-first-u...

Global PCR and Realtime PCR Testing Market Report 2021: COVID-19 Impacts, Implications and Growth Forecast to 2025 & 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 5, 2021
Infectious diseases, General Health, Health, Branches of biology, Polymerase chain reaction, Molecular biology, Natural sciences, Laboratory techniques, Biology, Real-time polymerase chain reaction, Polymerase, RT PCR, Reverse transcription polymerase chain reaction

Global Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion\n6.2.

Key Points: 
  • Global Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion\n6.2.
  • Global Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion\n6.3.
  • Global Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) Testing Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion\n7.2.
  • Global Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) Testing Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion\n'

Calgary Based Travel Clinic expanding Private Covid Testing to all major cities in Canada

Retrieved on: 
Tuesday, April 27, 2021
Branches of biology, Life sciences, Biology, Biotechnology, Molecular biology, Laboratory techniques, Immunologic tests, Chromatography, Rapid antigen test, Polymerase chain reaction, COVID-19, RT PCR

b'CALGARY, AB, April 27, 2021 /CNW/ - Head quartered in Calgary, Canadian Travel Clinics is one of the leading names in the travel healthcare industry of Canada.

Key Points: 
  • b'CALGARY, AB, April 27, 2021 /CNW/ - Head quartered in Calgary, Canadian Travel Clinics is one of the leading names in the travel healthcare industry of Canada.
  • The company\'s successful expansion in providing Covid-19 RT-PCR testing is 100 percent patient focused and currently operates from 5 locations across Calgary, Edmonton, Winnipeg & Vancouver.
  • Founded in 2016 by Usman Hashmi & Michele Fasolino, the company provides travel vaccinations and comprehensive Covid-19 RT-PCR Swab Test, Antigen test & Antibody Testsolutions to travelers and businesses.
  • We are trying to make essential travel more affordable for public during these difficult times.

PathogenDx Applauded by Frost & Sullivan for Its Ultra-rapid COVID-19 Testing Platform, DetectX-Rv Test

Retrieved on: 
Monday, March 22, 2021
Branches of biology, Natural sciences, Biology, Molecular biology, Laboratory techniques, Polymerase chain reaction, Biotechnology, Amplifiers, COVID-19 testing, Reverse transcription polymerase chain reaction, RT PCR, DNA microarray

PathogenDx adapted its unique testing platform by combining multiplexed end-point, real-time polymerase chain reaction (RT-PCR) with DNA microarray technology to enable testing for COVID-19 in people, in the air, and on contact surfaces.

Key Points: 
  • PathogenDx adapted its unique testing platform by combining multiplexed end-point, real-time polymerase chain reaction (RT-PCR) with DNA microarray technology to enable testing for COVID-19 in people, in the air, and on contact surfaces.
  • "With an ultra-rapid sample-to-result testing turnaround time of four and a half hours, PathogenDx aims to simplify and expedite COVID-19 detection.
  • Furthermore, PathogenDx provides its environmental screening and monitoring EnviroX-Rv test for public facilities and buildings lacking ventilation.
  • Each year, Frost & Sullivan presents this award to the company that demonstrates uniqueness in developing and leveraging new technologies that deliver significant customer value.

PathogenDx Applauded by Frost & Sullivan for Its Ultra-rapid COVID-19 Testing Platform, DetectX-Rv Test

Retrieved on: 
Monday, March 22, 2021
Branches of biology, Natural sciences, Biology, Molecular biology, Laboratory techniques, Polymerase chain reaction, Biotechnology, Amplifiers, COVID-19 testing, Reverse transcription polymerase chain reaction, RT PCR, DNA microarray

PathogenDx adapted its unique testing platform by combining multiplexed end-point, real-time polymerase chain reaction (RT-PCR) with DNA microarray technology to enable testing for COVID-19 in people, in the air, and on contact surfaces.

Key Points: 
  • PathogenDx adapted its unique testing platform by combining multiplexed end-point, real-time polymerase chain reaction (RT-PCR) with DNA microarray technology to enable testing for COVID-19 in people, in the air, and on contact surfaces.
  • "With an ultra-rapid sample-to-result testing turnaround time of four and a half hours, PathogenDx aims to simplify and expedite COVID-19 detection.
  • Furthermore, PathogenDx provides its environmental screening and monitoring EnviroX-Rv test for public facilities and buildings lacking ventilation.
  • Each year, Frost & Sullivan presents this award to the company that demonstrates uniqueness in developing and leveraging new technologies that deliver significant customer value.

Sunquest Lauded by Frost & Sullivan for Driving Efficiency and Compliance with Its Differentiated Molecular Laboratory Information Management System

Retrieved on: 
Tuesday, March 2, 2021
Branches of biology, Biology, Molecular biology, Life sciences, Biotechnology, Laboratory techniques, Polymerase chain reaction, Amplifiers, RT PCR, Reverse transcription polymerase chain reaction, Laboratory information management system, Massive parallel sequencing

Sunquest's comprehensive portfolio of products and services improves operational efficiency, enhances patient care, and lowers healthcare organizations' costs across the spectrum.

Key Points: 
  • Sunquest's comprehensive portfolio of products and services improves operational efficiency, enhances patient care, and lowers healthcare organizations' costs across the spectrum.
  • Sunquest Mitogen supports multiple molecular workflows such as polymerase chain reaction (PCR), reverse transcription-polymerase chain reaction (RT-PCR), next-generation sequencing (NGS), chromosomal microarray (CMA), and mass spectrometry.
  • While other existing LIMS products are compatible with only about two workflows, Sunquest Mitogen supports more than 10 workflows.
  • "Sunquest strategically leverages its sister company, Data Innovations, vast collection of instrument drivers to makeSunquest Mitogen LIMS instrument-agnostic.

Sunquest Lauded by Frost & Sullivan for Driving Efficiency and Compliance with Its Differentiated Molecular Laboratory Information Management System

Retrieved on: 
Tuesday, March 2, 2021
Branches of biology, Biology, Molecular biology, Life sciences, Biotechnology, Laboratory techniques, Polymerase chain reaction, Amplifiers, RT PCR, Reverse transcription polymerase chain reaction, Laboratory information management system, Massive parallel sequencing

Sunquest's comprehensive portfolio of products and services improves operational efficiency, enhances patient care, and lowers healthcare organizations' costs across the spectrum.

Key Points: 
  • Sunquest's comprehensive portfolio of products and services improves operational efficiency, enhances patient care, and lowers healthcare organizations' costs across the spectrum.
  • Sunquest Mitogen supports multiple molecular workflows such as polymerase chain reaction (PCR), reverse transcription-polymerase chain reaction (RT-PCR), next-generation sequencing (NGS), chromosomal microarray (CMA), and mass spectrometry.
  • While other existing LIMS products are compatible with only about two workflows, Sunquest Mitogen supports more than 10 workflows.
  • "Sunquest strategically leverages its sister company, Data Innovations, vast collection of instrument drivers to makeSunquest Mitogen LIMS instrument-agnostic.

BrainChip Inc. and NaNose Medical Successfully Detect COVID-19 in Exhaled Breath with Fast High-Accuracy Results

Retrieved on: 
Wednesday, February 24, 2021
Software, Hardware, Health, Medical devices, Data management, Infectious diseases, Technology, Other Technology, Molecular biology, Laboratory techniques, Natural sciences, Branches of biology, Biology, Biotechnology, Polymerase chain reaction, RT PCR, Reverse transcription polymerase chain reaction, Polymerase

NaNose Medical is currently collecting samples from three primary worldwide locations and will work with BrainChip to evaluate the data.

Key Points: 
  • NaNose Medical is currently collecting samples from three primary worldwide locations and will work with BrainChip to evaluate the data.
  • A study in China confirmed that breath sensor data is more accurate than the reverse transcription polymerase chain reaction (RT-PCR) test typically used.
  • Accurate testing is key at early stages, even before symptoms manifest, and after treatment before patients are discharged into their communities.
  • Akida is designed to provide a complete ultra-low power and fast AI Edge Network for vision, audio, olfactory and smart transducer applications.